The effects of chronic lymphocytic leukemia (CLL) on a patient
Why CLL presents differently from patient to patient
What treatments are available when CLL advances
Managing side effects to promote a better quality of life
The importance of open communication with your healthcare team
Susan O’Brien, MD
Associate Director of Clinical Science, Chao Family Comprehensive Cancer Center
Medical Director, Sue and Ralph Stern Center for Clinical Trials & Research
Professor of Medicine, Division of Hematology/Oncology, Department of Medicine
University of California
Support for this program provided by Genentech & Biogen, Gilead Sciences, Inc., Infinity Pharmaceuticals, Pharmacyclics, Inc. & Janssen Biotech, Inc., an educational grant from Teva Pharmaceuticals, and The Leukemia & Lymphoma Society.
For any questions or comments about this program, please email feedback@LLS.org.